Funds and ETFs Pharmanutra S.p.A.

Equities

PHN

IT0005274094

Pharmaceuticals

Market Closed - Borsa Italiana 11:44:59 2024-04-29 am EDT 5-day change 1st Jan Change
54 EUR +1.31% Intraday chart for Pharmanutra S.p.A. +2.47% -4.26%

ETFs positioned on Pharmanutra S.p.A.

Name Weight AuM 1st Jan change Investor Rating
0.00% 10 M€ -3.35% -
Pharmanutra SpA is an Italy-based company engaged in the healthcare industry. The Company develops nutraceutical products and medical devices. It focuses on studying and producing formulations that are backed up in scientific research. It is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The Company offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
54 EUR
Average target price
80.67 EUR
Spread / Average Target
+49.38%
Consensus
  1. Stock Market
  2. Equities
  3. PHN Stock
  4. Funds and ETFs Pharmanutra S.p.A.